• Hepatic Cellular Uptake of PEGylated Iron Oxide Nanoparticle

  2026-06-03

  This study elucidates how the physicochemical properties—particularly particle size and PEG chain length—govern the hepatic cellular interactions and biodistribution of iron oxide nanoparticles. Insights into cell-type specific uptake challenge conventional paradigms and inform the rational design of nanomedicines with improved targeting and safety profiles.

• Berberine Modulates SIRT6-AMPK to Inhibit NLRP3 in AF Models

  2026-06-03

  This study elucidates how berberine attenuates atrial remodeling and fibrosis by upregulating the SIRT6-AMPK pathway, leading to inhibition of NLRP3 inflammasome activation in angiotensin II-induced murine models of atrial fibrillation. The findings highlight a mechanistic link between metabolic regulation and inflammation in cardiac pathology, suggesting new avenues for targeted anti-arrhythmic interventions.

• PPT (Propyl Pyrazole Triol): Empowering ERα Research Workflo

  2026-06-02

  PPT (Propyl Pyrazole Triol) transforms selective ERα signaling studies with unmatched specificity and robust solubility. Discover how this tool accelerates biomarker validation, troubleshooting, and translational research in oncology and beyond.

• SP600125: Shaping JNK Inhibition for Translational Innovatio

  2026-06-02

  This thought-leadership article explores the mechanistic depth and strategic potential of SP600125, a selective JNK inhibitor, for translational researchers. Integrating recent findings on cellular stress signaling, the review highlights SP600125’s unique role in apoptosis, inflammation, and cytokine modulation—framing actionable guidance for designing robust, reproducible experiments and bridging insights from redox biology to advanced disease modeling. The discussion advances beyond canonical applications, evaluating competitive alternatives and projecting future directions for JNK pathway targeting in translational contexts.

• Novobiocin: Aminocoumarin Antibiotic in Applied Antimicrobia

  2026-06-01

  Novobiocin stands out as a dual-action aminocoumarin antibiotic, offering unique leverage points for antibacterial, antiparasitic, and antiviral bench workflows. This guide translates recent protoplast research and cross-domain innovations into actionable protocols, troubleshooting strategies, and performance optimization for resistance and apoptosis studies.

• Applied Use-Cases of Palbociclib (PD0332991) in Cell Cycle R

  2026-06-01

  Palbociclib (PD0332991) Isethionate stands out as a precise tool for dissecting cell cycle checkpoints and apoptosis in cancer models, offering robust G0/G1 arrest and translational relevance. This guide delivers protocol-driven insights, troubleshooting strategies, and cross-study comparisons to maximize impact in breast and renal carcinoma research.

• Neuroinflammation and Piezo2 Signaling in Trigeminal Neuralg

  2026-05-31

  Liao et al. uncover a neuroinflammatory feedback loop linking trigeminal nerve root compression to mechanical allodynia through the CGRP/SP-Piezo2 axis and Ca2+-dependent signaling. Their integrative in vivo and in vitro approach clarifies the molecular mechanisms of peripheral sensitization in trigeminal neuralgia, highlighting novel targets for pain research.

• Ferrostatin-1: Optimizing Ferroptosis Assays in Disease Mode

  2026-05-30

  Ferrostatin-1 (Fer-1) empowers precise ferroptosis inhibition across cancer, neurodegeneration, and environmental toxicology models, with robust performance in lipid peroxidation and oxidative stress paradigms. This article delivers workflow-anchored guidance, highlights a breakthrough aquatic toxicology use-case, and arms researchers with troubleshooting tips for reproducibility and sensitivity.

• Obacunone Mitigates Neuroinflammation After Spinal Cord Inju

  2026-05-29

  This study demonstrates that obacunone, a natural limonoid, promotes functional recovery after spinal cord injury by inhibiting the TLR4/MyD88/p38 MAPK signaling pathway, thereby reducing neuroinflammation and neuronal apoptosis. The findings support obacunone as a promising candidate for further therapeutic development in central nervous system trauma.

• MRT68921 dual autophagy kinase ULK1/2 inhibitor: Experimenta

  2026-05-29

  This article addresses key laboratory challenges in autophagy research and demonstrates how MRT68921 dual autophagy kinase ULK1/2 inhibitor (SKU B6174) enables reproducible, high-sensitivity autophagy inhibition. Drawing on recent mechanistic insights and validated protocols, we compare MRT68921 to common alternatives, highlighting its utility for cell viability, proliferation, and cytotoxicity assays.

• Calpain Inhibitor I, ALLN: Technical Guidance for Research U

  2026-05-28

  Calpain Inhibitor I, ALLN (SKU A2602) is a potent, selective inhibitor targeting calpain and cathepsin proteases, optimized for use in apoptosis assays and ischemia-reperfusion injury models. It is not suitable for diagnostic or clinical applications; strict adherence to research protocols is required for reliable results.

• Nuclear cGAS Limits L1 Retrotransposition via TRIM41-ORF2p A

  2026-05-28

  This study reveals that nuclear cGAS suppresses LINE-1 (L1) retrotransposition by promoting TRIM41-mediated ubiquitination and degradation of L1-encoded ORF2p. These findings illuminate a posttranslational genome-protective mechanism with implications for aging, cancer, and DNA damage response research.

• A-1210477: Precision MCL-1 Inhibition for Cancer Research

  2026-05-27

  A-1210477 stands out as a potent, selective MCL-1 inhibitor, empowering researchers to dissect mitochondrial apoptosis in MCL-1-dependent cancer models. This article guides advanced workflows, troubleshooting, and experimental optimization, translating the latest mechanistic insights into actionable protocols for cancer research.

• Macrophage-Derived EV miR-660 Drives NF-κB Activation in Bre

  2026-05-27

  This study uncovers a tumor-promoting mechanism in breast cancer, where tumor-associated macrophages transmit microRNA-660 via extracellular vesicles to cancer cells, leading to enhanced NF-κB signaling and metastasis. The findings highlight miR-660 as a potential target for limiting breast cancer progression and underscore the importance of tumor microenvironment communication.

• TAI-1: Next-Generation Hec1 Inhibitor Advancing Cancer Resea

  2026-05-26

  Explore how TAI-1, a first-in-class Hec1 inhibitor, redefines cancer cell proliferation inhibition through precise mitotic disruption and enhanced selectivity. This article provides deep mechanistic insights, practical protocol guidance, and a critical comparison to emerging DNA damage modulation strategies.

453 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page